Page last updated: 2024-08-24

fluorodeoxyglucose f18 and dasatinib

fluorodeoxyglucose f18 has been researched along with dasatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, D; Gao, L; Jia, B; Liu, H; Liu, Z; Sun, X; Wang, F; Zhang, C; Zhu, Z	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and dasatinib

Article	Year
Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Animals; Antineoplastic Agents; Dasatinib; Drug Therapy, Combination; Fluorodeoxyglucose F18; Genes, src; Integrin alphaVbeta3; Luminescence; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasms; Radioligand Assay; Radiopharmaceuticals; Ranibizumab; Tomography, Emission-Computed, Single-Photon; Vascular Endothelial Growth Factor A	2016

Article

Year

Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2

Topics: Animals; Antineoplastic Agents; Dasatinib; Drug Therapy, Combination; Fluorodeoxyglucose F18; Genes, src; Integrin alphaVbeta3; Luminescence; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Neoplasms; Radioligand Assay; Radiopharmaceuticals; Ranibizumab; Tomography, Emission-Computed, Single-Photon; Vascular Endothelial Growth Factor A

2016